Pegah Jafarinasabian
AbbVie (United States)(US)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Nutrition and Health in Aging, CAR-T cell therapy research, Heart Failure Treatment and Management
Most-Cited Works
- → Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer(2022)437 cited
- → Aging human body: changes in bone, muscle and body fat with consequent changes in nutrient intake(2017)311 cited
- → Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval(2022)61 cited
- → A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma(2020)55 cited
- → First data for sotorasib in patients with pancreatic cancer with KRAS p.G12C mutation: A phase I/II study evaluating efficacy and safety(2022)43 cited
- → Abstract P05-01: A phase 1b study evaluating the safety and efficacy of sotorasib, a KRASG12C inhibitor, in combination with trametinib, a MEK inhibitor, in KRAS p.G12C-Mutated Solid Tumors(2021)35 cited
- → Epcoritamab Monotherapy in Patients (Pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from CLL Expansion and Optimization Cohorts of Epcore CLL-1(2024)29 cited
- → Effect of Varying Degrees of Renal Impairment on the Pharmacokinetics of Omecamtiv Mecarbil(2021)17 cited
- → 3-Year Update from the Epcore NHL-1 Trial: Epcoritamab Leads to Deep and Durable Responses in Relapsed or Refractory Large B-Cell Lymphoma(2024)16 cited
- → A phase 1b study of sotorasib, a specific and irreversible KRASG12C inhibitor, in combination with other anticancer therapies in advanced colorectal cancer (CRC) and other solid tumors (CodeBreaK 101).(2022)14 cited